Does radiation-induced fibrosis have an important role in pathophysiology of the osteoradionecrosis of jaw?

Medical Hypotheses

Volumn 77, Issue 1, 2011, Pages 63-65

  Zhuang, QianWei ^a   Zhang, ZhiYuan ^a   Fu, HongHai ^a   He, Jie ^a   He, Yue ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; JAW OSTEONECROSIS; PATHOPHYSIOLOGY; RADIATION DOSE; RADIATION INDUCED FIBRSIS; RADIATION SICKNESS;

FIBROSIS; HUMANS; JAW DISEASES; OSTEONECROSIS; RADIOTHERAPY;

EID: 79958070115     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.03.024     Document Type: Article

References (41)

1. Lee I.J., Koom W.S., Lee C.G., et al. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients. Int J Radiat Oncol Biol Phys 2009, 75(4):1084-1091.
2. Meyer I. Infectious diseases of the jaws. J Oral Surg 1970, 28(1):17-26.
3. Marx R.E. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 1983, 41(5):283-288.
4. Lyons A., Ghazali N. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg 2008, 46(8):653-660.
5. Strup-Perrot C., Mathé D., Linard C., et al. Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis. Am J Physiol Gastrointest Liver Physiol 2004, 287(4):G875-G885.
6. Haydont V., Vozenin-Brotons M.C. Maintenance of radiation-induced intestinal fibrosis: cellular and molecular features. World J Gastroenterol 2007, 13(19):2675-2683.
7. O'Sullivan B., Levin W. Late radiation-related fibrosis: pathogenesis, manifestations, and current management. Semin Radiat Oncol 2003, 13(3):274-289.
8. Gervaz P., Morel P., Vozenin-Brotons M.C. Molecular aspects of intestinal radiation-induced fibrosis. Curr Mol Med 2009, 9(3):273-280.
9. Thorn J.J., Hansen H.S., Specht L., et al. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg 2000, 58:1088-1093.
10. Harris M. The conservative management of osteoradionecrosis of the mandible with ultrasound therapy. Br J Oral Maxillofac Surg 1992, 30(5):313-318.
11. Schwartz H.C., Kagan A.R. Osteoradionecrosis of the mandible: scientific basis for clinical staging. Am J Clin Oncol 2002, 25(2):168-171.
12. Støre G., Boysen M. Mandibular osteoradionecrosis: clinical behavior and diagnostic aspects. Clin Otolaryngol Allied Sci 2000, 25(5):378-384.
13. Oh H.K., Chambers M.S., Martin J.W., et al. Osteoradionecrosis of the mandible: treatment outcomes and factors influencing the progress of osteoradionecrosis. J Oral Maxillofac Surg 2009, 67(7):1378-1386.
14. Marx RE, Stern D. Oral and maxillofacial pathology: a rationale for diagnosis and treatment. Chicago: Quintessence Publishing Co. Ltd.; 2003. p. 388-390.
15. Jegoux F., Malard O., Goyenvalle E., et al. Radiation effects on bone healing and reconstruction: interpretation of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 109(2):173-184.
16. Knospe W.H., Blom J., Crosby W.H. Regeneration of locally irradiated bone marrow. I. Dose dependent, long-term changes in the rat, with particular emphasis upon vascular and stromal reaction. Blood 1966, 28:398-415.
17. van Os R., Thames H.D., Konings A.W., et al. Radiation dose-fractionation and dose-rate relationships for long-term re-populating hemopoietic stem cells in a murine bone marrow transplant model. Radiat Res 1993, 136:118-125.
18. Ikeda S., Hachisu R., Yamaguchi A., Gao Y.H., Okano T. Radiation retards muscle differentiation but does not affect osteoblastic differentiation induced by bone morphogenetic protein-2 in C2C12 myoblasts. Int J Radiat Biol 2000, 76:403-411.
19. Han B., Yang Z., Nimni M. Effects of gamma irradiation on osteoinduction associated with demineralized bone matrix. J Orthop Res 2008, 26:75-82.
20. Sakurai T., Sawada Y., Yoshimoto M., Kawai M., Miyakoshi J. Radiation-induced reduction of osteoblast differentiation in C2C12 cells. J Radiat Res (Tokyo) 2007, 48:515-521.
21. Barcellos-Hoff M.H. How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Radiat Res 1998, 150(5 Suppl):S109-S120.
22. Delanian S., Lefaix J.L.T. He radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol 2004, 73:119-131.
23. Pepper M.S. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997, 8:21-43.
24. Gabbiani G. Modulation of fibroblastic cytoskeletal features during wound healing and fibrosis. Pathol Res Pract 1994, 190(9-10):851-853.
25. Delanian S., Lefaix J.L. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol 2007, 17:99-107.
26. Delanian S., Martin M., Housset M. Iatrogenic fibrosis in oncology (part e{capital schwa}): descriptive and pathophysiological aspects. Bull Cancer 1993, 80:192-201.
27. Lefaix J.-L., Daburon F. Diagnosis of acute localized irradiation lesions: a review of French experimental experience. Health Phys 1998, 75:375-384.
28. Basavaraju S.R., Easterly C.E. Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 2002, 29:2391-2403.
29. Shukla A., Meisler N., Cutroneo K.R. Perspective article: transforming growth factor-beta: crossroad of glucocorticoid and bleomycin regulation of collagen synthesis in lung fibroblasts. Wound Repair Regen 1999, 7:133-140.
30. Barcellos-Hoff M.H. How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Radiat Res 1998, 150:S109-S120.
31. Furukawa F., Matsuzaki K., Mori S., et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 2003, 38:879-889.
32. Gervaz P., Morel P., Vozenin-Brotons M.C. Molecular aspects of intestinal radiation-induced fibrosis. Curr Mol Med 2009, 9(3):273-280.
33. Burger A., Löffler H., Bamberg M., et al. Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol 1998, 73:401-408.
34. Von Pfeil A., Hakenjos L., Herskind C., et al. Irradiated homozygous TGF-beta1 knockout fibroblasts show enhanced clonogenic survival as compared with TGF-beta1 wild-type fibroblasts. Int J Radiat Biol 2002, 78:331-339.
35. Vujaskovic Z., Anscher M.S., Feng Q.F., et al. Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 2001, 50:851-855.
36. Vodovotz Y., Lucia M.S., DeLucca A.M., et al. Reduced hematopoietic function and enhanced radiosensitivity of transforming growth factor-beta1 transgenic mice. Int J Cancer 2000, 90:13-21.
37. Canney P., Dean S. Transforming growth factor beta: a promoter of late connective tissue injury following radiotherapy?. Br J Radiol 1990, 63:620-623.
38. Border W.A., Noble N.A. Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994, 331:1286-1292.
39. Xavier S., Piek E., Fujii M., et al. Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. J Biol Chem 2004, 279:15167-15176.
40. McGaha T.L., Phelps R.G., Spiera H., et al. Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming growth-factor-beta-mediated Smad3 activation in fibroblasts. J Invest Dermatol 2002, 118:461-470.
41. Maeda A., Hiyama K., Yamakido H., et al. Increased expression of platelet derived growth factor A and insulin like growth factor-1 in BAL cells during the development of bleomycin induced pulmonary fibrosis in mice. Chest 1996, 109:780-786.